Abstract
Pancreatic and liver cancers, characterized by elevated mortality rates, pose significant challenges in chemotherapy, leading to the exploration of novel therapeutic approaches. Cathepsins B, L, and S have been identified as key players in the neoplastic process, offering potential targets for covalent reversible and irreversible inhibitors using dipeptidyl nitrile derivatives. Dipeptidyl…